ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CLBT
Cellebrite DI Ltd.
CLBT has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CLBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CLBT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CLBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $1.64 | -85% |
| Forward | 33x | $10.89 | — |
| Fair | 44x | $10.10 | -7.3% |
| Current | 47x | $10.89 | — |
| Expensive | 62x | $14.35 | +32% |
Historical ranges are pointers, not guarantees.
CLBT's PE is in its fair range at 47x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CLBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CLBT, but weaker profitability.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CLBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +46% |
| Q2 2026 | $0.23 | +$0.99 |
| Q1 2026 | $0.29 | +$1.25 |
| Q4 2025 | $0.31 | +$1.70 |
| Q3 2025 | $0.31 | +$1.86 |
| Q2 2025 | -$0.76 | -$0.24 |
| Q1 2025 | -$0.96 | -$0.39 |
| Q4 2024 | -$1.39 | -$0.96 |
| Q3 2024 | -$1.55 | -$1.23 |
CLBT has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CLBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $131.1M | +16% |
| Q1 2026 | $128.3M | +19% |
| Q4 2025 | $128.8M | +18% |
| Q3 2025 | $126M | +18% |
| Q2 2025 | $113.3M | +18% |
| Q1 2025 | $107.5M | +20% |
| Q4 2024 | $109M | +17% |
| Q3 2024 | $106.9M | +27% |
CLBT's revenue has grown year over year every quarter since early 2021: $131M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.8% | -6.9 points |
| Q1 2026 | 7.1% | -4.3 points |
| Q4 2025 | 16% | +1.7 points |
| Q3 2025 | 15% | -3.1 points |
| Q2 2025 | 13% | -0.3 points |
| Q1 2025 | 11% | +1.1 points |
| Q4 2024 | 14% | -1.7 points |
| Q3 2024 | 18% | +2.2 points |
CLBT has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CLBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $14.5M | -50% |
| Q1 2026 | $16.8M | -9.1% |
| Q4 2025 | $78.3M | +27% |
| Q3 2025 | $30M | -25% |
| Q2 2025 | $29M | +138% |
| Q1 2025 | $18.5M | +134% |
| Q4 2024 | $61.7M | +59% |
| Q3 2024 | $39.8M | +42% |
CLBT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CLBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +711K shares |
| 1 year | +1.5% | +3.8M shares |
| 3 years | +34% | +64.7M shares |
| 5 years | +35% | +65.6M shares |
| Available history | +35% | +65.6M shares |
CLBT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $11,000 |
CLBT hasn't bought back shares in the past year.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
| Q2 2023 | -0.6x | Net Cash |
| Q1 2023 | -0.4x | Net Cash |
| Q4 2022 | -0.3x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
CLBT has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CLBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 32.9 | Neutral |
CLBT's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CLBT PE vs Technology Sector
| Metric | CLBT | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 67% above |
| PE % | 55 | 39 | 16 pts above |
CLBT is trading at 47x earnings, a 67% premium to the Technology sector's median of 28x, though its recent earnings include one-off gains.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over CLBT on trend strength, trading above more of its moving averages.
CLBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 5.1% below |
| 20 week MA | $12.6 | 14% below |
| 50 week MA | $13.9 | 22% below |
| 100 week MA | $16.1 | 32% below |
| 200 week MA | $13.1 | 17% below |
CLBT is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CLBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.66 | $10.5 | +8.8% |
| 2021 | $10.5 | $8.10 | -23% |
| 2022 | $8.10 | $4.18 | -48% |
| 2023 | $4.18 | $8.66 | +107% |
| 2024 | $8.66 | $22.2 | +156% |
| 2025 | $22.2 | $18.4 | -17% |
| 2026 YTD | $18.4 | $10.9 | -41% |
CLBT has the edge over ASTS on returns for 2026, with the stronger performance.